Influence of Cytotoxic Drugs on Platelet Functions and Coagulation in vitro.

Summary

Influence of melphalan on some platelet functions, plasmatic coagulation and fibrinolysis “in vitro” was investigated, using different concentrations of the drug (25, 50 and 250 μg/ml). The lowest concentration slightly inhibited adrenaline and/or collagen-induced platelet aggregation. Following the highest concentration of the drug, strong inhibition of aggregation was recorded, regardless of the inducer used. Melphalan was also shown to inhibit release of aggregating activity and release of platelet factor 4, as well as availibility of platelet factor 3 and platelet acid phosphatase. The intensity of inhibition depended on both, melphalan concentration and the time of preincubation. In contrast to this, adhesion of platelets to glass slide was not found to be influenced by melphalan. Similarly, melphalan did not induce (in any concentration) loss of LDH from platelet cytoplasma, while triton X-100 or freezing and thawing of platelets caused significant increase of LDH activity. From coagulation tests studied, only thrombin time and reptilase time was found to be moderately prolonged in the presence of melphalan.

Authors assumed that melphalan acts as a specific inhibitor of release reaction and can induce an acquired thrombocytopathy. The platelet membrane is not damaged by the drug, as was confirmed by the investigation of LDH activity. Influence on coagulation indicates some antithrombin effect of the drug. Although presented results were obtained in vitro, analogous changes in vivo could be suspected. Thus, impairement of platelet functions might play a part in haemorrhagic complications accompanying, in some cases, melphalan therapy.

• References

• 1 Alexanian R, Bergsagel D.E, Migliore P.J, Vaughn K.W, Howe D.C. Melphalantherapy for plasma cell myeloma. Blood 1968; 31: 1
• 2 Bergmeyer H.V, Bernt E, Hess B. Lactic dehydrogenase. In: Bergmeyer H.V. (Ed.) Methods of enzymatic analysis 1965. New York: Academic Press; 736
• 3 Caen J, Larrieu M.J, Samama M. L’hémostase. Méthodes d’exploration et diagnostic pratique. 1975. L’expansion Scientifique Française; Paris: 383
• 4 Fisher B, Carbone P, Economou S.G, Frelick R, Glass A, Lerner H, Redmond C. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. New England Journal of Medicine 1975; 292: 117
• 5 Holmsen H, Day H.J, Stormorken H. The blood platelet release reaction. Scandinavian Journal of Haematology Suppl. 1969; 8: 25
• 6 Hoogstraten B, Sheehe P.R, Cuttner J, Cooper T, Kyle R.A, Oberfield R.A, Townsend S.R, Harley J.B, Hayes D.B, Costa G, Holland J.F. Melphalan in multiple myeloma. Blood 1967; 30: 74
• 7 Joist J.H, Dolezel G, Lloyd J.V, Kinlough-Rathbone R.L. Platelet factor 3 availibility and the platelet release reaction. Journal of Laboratory and Clinical Medicine 1974; 84: 474
• 8 Klener P. Use of cytotoxic drugs in haematology (In Czech) Praha. Avicenum 1974; 286
• 9 Klener P, Kubisz P, Suranová J. Influence of cytotoxic drugs on platelet functions in vitro. III. Peptichemio. Acta haematologica (Basel) 1975; 54: 46
• 10 Kováčová J, Kubisz P. Estimation of platelet adhesion to a glass by modified Masson and Gilkey’s method (In Slovak). Bratislavské lékařské listy (in press) 1975
• 11 Kováčová J, Kubisz P. Unpublished observation. 1976
• 12 Kubisz P. Blood platelet and its disorders. Acta Universitatis Carolinae, Medica 1975; 21: 232
• 13 Kubisz P. Platelet release reaction and clot retraction. Thrombosis et Diathesis Haemorrhagica 1973; 30: 224
• 14 Kubisz P, Suranová J. On the mechanism by which bovine fibrinogen induces release and availibility of human blood platelets. Thrombosis et Diathesis Haemorrhagica 1973; 29: 416
• 15 Kubisz P, Suranová J. Influence of cytotoxic drugs on some platelet functions “in vitro” I. Rubidomycin (In Slovak) Vnitřní lékarství 1974; a 20: 573
• 16 Kubisz P, Suranová J. Influence of cytostatics on some functions of blood platelets “in vitro”. II. Cytosine arabinoside. Neoplasma 1974; b 21: 711
• 17 Kwaan H.C, Barlow G.H. The mechanism of action of arvin and reptilase. Thrombosis et Diathesis Haemorrhagica 1971; 25: 214
• 18 Mac Millan D.C. Secondary clumping effect in human citrated platelet rich plasma produced by ADP and adrenaline. Nature, London 1966; 211: 140
• 19 Mason R.G, Gilkey J.H. A simple test for quantitation of platelet adhesion to glass. Studies in bleeder and non-bleeder subjects. Thrombosis et Diathesis Haemorrhagica 1971; 25: 21
• 20 Mayr A.C, Nagel G.A, Dick H.J, Obrecht J.P. Nebenwirkungen der Zytostatika. Schweizerische Medizinische Wochenschrift 1973; 103: 1252
• 21 Nilson I.M. Haemorrhagic and thrombotic disease. 1974. Wiley; London: 288
• 22 Piette M, Piette C. Numération des plaquettes sanguines utilisant un liquide hypotonique de chlorhydrate de procaine. Sang 1959; 30: 144
• 23 Sinacos Z, Caen J. Une technique simple quantitative de mesure de l’aggregation plaquettaire. Revue Française Études Cliniques et Biologiques 1969; 11: 359
• 24 Stuart M.J. Inherited defects of platelet functions Seminars in Hematology 1975; 12: 233
• 25 Walton M.R. Cancer chemotherapy. British Journal of Clinical Practice 1972; 26: 159
• 26 Wand H, Rieche K. Zytostatikawirkung auf Thrombozyten und Lymphozyten von Tumorpatienten. Folia Haematologica (Leipzig) 1974; 101: 800